Saraf and Partners acts for Viatris in divestment of its Women’s Healthcare business, and Active Pharmaceutical Ingredients (API) business in India.
02nd October, 2023: Global healthcare leader Viatris, (formerly known as Mylan), has taken a significant step towards its strategic goals by entering into agreements on October 1st to divest key business segments, including its Women’s Healthcare and Active Pharmaceutical Ingredients (API) businesses. The total consideration for these divestments amounts to a substantial USD 1.2 billion.
Saraf and Partners Bolsters its team with the addition of Dhruv Chatterjee as Partner in Corporate, M&A, and Private Equity practices
September 27, 2023, New Delhi: Saraf and Partners is pleased to welcome Dhruv Chatterjee as a Partner in the Corporate, M&A and Private Equity practice of the Firm.
Saraf and Partners Strengthens Tax Practice with the Addition of Amit Gupta as Partner
Saraf and Partners is pleased to welcome Amit Gupta as a Partner in the Tax practice.
Saraf and Partners successfully represents AGI Greenpac Limited in defending its CCI approval for acquiring HNGIL
Saraf and Partners successfully represented AGI Greenpac Limited and obtained a landmark order before the Hon’ble National Company Law Appellate Tribunal, New Delhi (NCLAT).
Saraf and Partners acts on sale by Fortis Healthcare of its hospital situated at Vadapalani, Chennai to Kauvery Hospitals
Fortis Healthcare Limited has entered into a definitive agreement with Sri Kauvery Medical Care (India) Limited for sale of its hospital (together with its business operations) situated at Arcot Road, Vadapalani, Chennai, Tamil Nadu, for a consideration of USD 18.5 million/INR 152 crores.The Arcot Road Hospital which is located on leased premises currently has 110 …
Saraf and Partners announces Annual Promotion for 2023.
Saraf and Partners, a leading full-service law Firm, announced promotion for 2023-24, followed by Celebration across all offices.